Histidine decarboxylase inhibitor sole or combined with a leukotriene receptor antagonist, an anti-H1 and/or an anti-H2 to treat COPD or gastrointestinal disorders.

摘要

The invention provides a method for the treatment and prevention of food allergy, and food anaphylaxis disease and conditions ameliorated by histamine management in a subject, comprising administering to the subject an effective amount of a histidine decarboxylase inhibitor sole or with anti-H1 drug or with an anti-H2 drug, or with LRA (Leucotriene Receptor Antagonist).